Science topics: Medicine
Science topic

Medicine - Science topic

Explore the latest questions and answers in Medicine, and find Medicine experts.
Questions related to Medicine
  • asked a question related to Medicine
Question
1 answer
Are there any recent developments or plans to introduce a DM (Doctorate of Medicine) course in Anatomy, and what would be its potential focus areas and impact on the field?
Relevant answer
Answer
My opinion here is to recommend for DM (Doctorate of Medicine) course in Anatomy,and it should focus mainly on the clinical aspect of Anatomy.
For E.g,during surgeries,Ultrasonography, Drugs administration etc...it will be of great interest to a clinician to know the exact anatomical location, shape and size of the tissue,organ he wants to treat.
  • asked a question related to Medicine
Question
1 answer
#journal friends
We are a Chinese education company dedicated to helping our clients publish SCI, SCIE, SSCI WoS indexes quickly. We have a wide range of paper orders in various fields and we are actively looking for partners who can help us with our publishing work.
Please note that your service fee will be paid after acceptance and it is necessary for you to share your login information with me.
This precaution is taken to avoid any potential fraudulent activity, as unfortunately there are many dishonest people in the market and I am reluctant to work with them.
If you meet the above requirements, please feel free to contact me
Relevant answer
Answer
hi. please send me a DM
  • asked a question related to Medicine
Question
85 answers
How do you think artificial intelligence can affect medicine in real world. There are many science-fiction dreams in this regard!
but how about real-life in the next 2-3 decades!?
Relevant answer
Answer
AI could pose pandemic-scale biosecurity risks. Here’s how to make it safer
"Advances in artificial intelligence (AI) promise to transform biomedical research, but could pose significant biosafety and biosecurity risks, argue three public health researchers and two policy researchers. They urge governments and AI developers to work with safety and security experts to mitigate harms that could result in the greatest loss of life and disruption to society, such as outbreaks of transmissible pathogens. That means building a scientific consensus through processes that engage diverse, independent experts..."
  • asked a question related to Medicine
Question
4 answers
I am a senior medical student in Zagazig University faculty of medicine (Egypt) with a strong interest in neurology, cardiology, and hematology/oncology, and I am eager to expand my research experience in these fields. I have foundational knowledge in medical research methods such as SRMA and have participated in clinical and laboratory-based projects during my studies.
I would like to inquire if there are any ongoing research projects or collaborations within these specialties where I could contribute, either through data analysis, literature reviews, or hands-on assistance in clinical studies. I am also open to participating in interdisciplinary projects related to general medicine.
Any advice or suggestions for getting involved in current research initiatives or learning opportunities in these areas would be greatly appreciated.
Thank you!
Relevant answer
Answer
hey, Dr Joseph, Yes I've tried and sadly they reject.
  • asked a question related to Medicine
Question
1 answer
Can AI combined with medicine cure cancer, leukaemia and other terminal diseases?
Relevant answer
Answer
AI is a tool that facilitates research. On its own cannot accomplished anything meaningful therapeutically, but it can help to select best direction and formulate a hypothesis. Once the hypothesis is formulated it needs to be proven or disproven using hard work and animal studies before submission of clinical protocol of clinical trial in human suffering from cancer can be even submitted for consideration to the Regulatory Agencies (Health Canada, FDA or European Regulatory Agency.
  • asked a question related to Medicine
Question
4 answers
How is polylactic acid used in medicine?
Relevant answer
Answer
Hello Xi Chen
I find this to be an excellent source of information on the topic you mentioned:
Have you seen it already, also?
  • asked a question related to Medicine
Question
6 answers
Hello, I’m a second-year medical student eager to develop my research skills, particularly in cardiology and the surgical field. I’m looking for guidance on how to start exploring research opportunities in these areas. Does anyone have any idea where to get started?
Relevant answer
Answer
I would agree with Dr Osvaldo Valdés Dupeyrón to start by looking fpor opportunities at yur own organisation/university/hospital. Maybe you've done that already (?) - helpful?
  • asked a question related to Medicine
Question
8 answers
Dear Scientists...
Hello everyone sincerely.
Today (November 3, 2024), the 9th World One Health Day...
I would like to open a topic that I am curious about for discussion. If you share your valuable opinions, I would be grateful.
Some scientists say the following when speaking about ONE HEALTH or in their scientific articles: The term "One Health" is not new. In fact, the origin of the idea begins with Hippocrates. Because they say, "Hippocrates was the first person to define and say that diseases are affected by the environment, air, and water."
Okay, it is impossible not to agree with this.
But as far as we know, during the time Hippocrates lived, there was "only" Medicine (human medicine). Even under the conditions of that day, there was no scientific Veterinary Medicine yet. The first scientific Veterinary Medicine education had started in 1762.
If "One Health is a collaborative, multisectoral, and transdisciplinary approach - working at local, national, and global levels - to achieve optimal health and well-being outcomes recognizing the interconnections between people, animals, plants, and their shared environment." how can Hippocrates be a "pioneer"? Also, since the concept and approach of "collaborative, multisectoral, and transdisciplinary approach" emphasized in the definition above did not exist during the Hippocratic period, isn't it contradictory to extend the "pioneer" of the ONE HEALTH THOUGHT beyond Virchow?
Moreover, Dr. Virchow's "There is no dividing line between human medicine and animal medicine - nor should there be. Even if the objects studied are different, the experience to be gained forms the basis of all medicine." Similar to the proposition, there is no call or proposition for "interprofessional cooperation" in Hippocrates... Unless, of course, the scientific archive is misleading me...
I am curious about your thoughts on this subject.
Best regards.
Rüştü TAŞTAN (rustu_tastan@yahoo.com.tr )
Relevant answer
Answer
Rudolf Virchow is generally considered the pioneer of the "One Health" concept, though the philosophy behind it can also be traced back to Hippocrates. Virchow, a 19th-century physician and pathologist, is credited with the term “zoonosis” and emphasized the interconnectedness of human, animal, and environmental health. He believed that studying diseases in animals was essential for understanding and managing human diseases. His holistic view of health laid the groundwork for the modern One Health framework, which addresses health issues at the human-animal-environment interface.
On the other hand, Hippocrates, often called the "Father of Medicine," introduced early ideas of environmental influence on health in his work, On Airs, Waters, and Places. He argued that factors like climate, water quality, and living conditions affect human health, a notion that aligns with One Health principles. However, he did not emphasize animal health specifically in this context.
While Hippocrates laid a foundation, Virchow’s explicit recognition of the human-animal connection places him as the more direct pioneer of what evolved into the One Health concept.
  • asked a question related to Medicine
Question
3 answers
I am a fifth-year medical student preparing to begin my clerkship soon. I am reaching out to inquire about potential research collaboration opportunities in the fields of neurosurgery, neurology, and neuroscience.
I have gained valuable experience working on various research projects throughout my studies and I am eager to further develop my skills and contribute to meaningful research in these areas. While I have not yet had the opportunity to publish my work, I am committed to advancing my knowledge the expertise in the field.
If you are aware of any ongoing projects or opportunities for collaboration, I would greatly appreciate your guidance or any connections you could provide. I am enthusiastic about the possibility of contributing to impactful research and learning from experienced professionals in the field.
Relevant answer
Answer
Hello, dear future colleague Allaham,
Approaching MS from a surgical vista has been the intention of www.ms-info.net. But, as Xun Liu warns above, you had better first find out whether clinical medicine might not clash with medical research here!
Best wishes as well
  • asked a question related to Medicine
Question
1 answer
Nanotechnology Based Medicine
#Nanotechnology #Medicine #HealthcareInnovation #FutureOfMedicine
Relevant answer
Answer
Nanotechnologias are very good access from interstiti throug réticulum endoplasmic along to nucleus potentially
  • asked a question related to Medicine
Question
2 answers
Dr. Faria is associated with Department of Biochemistry (U38-FCT), Faculty of Medicine, University of Porto , 4200-319 Porto, Portugal.
Relevant answer
Answer
Dear Dr. Brown,
Below is the email address of Dr. Faria.
Tel./Fax: +351 22 551 36 24
You may refer to the article attached below.
Best.
  • asked a question related to Medicine
Question
3 answers
As I teach disabilities and we talk about causes, treatment etc. Certain disabilities like intelectual impairment and autism along with epilepsy where cause is microcephaly, low birth weight still there is no treatment. It's life time dependency on medicine to avoid fits.
Relevant answer
Answer
It's good to see you realize that "current approaches focus mainly on symptom management rather than [causally, etiologically, or just pathogenetically orientated, physically grounded] cures," Dr. Agbo.
... By the way: Should "congenital" be understood as (we were taught to do!) sth. Hereditary, gene-determined, or as connatal, by anything?
  • asked a question related to Medicine
Question
1 answer
Acabei de publicar um livro sobre a ética da emancipação da medicina tradicional moçambicana:
Na sua opinião, o que deve acontecer para que haja maior valorização da medicina tradicional?
Relevant answer
Answer
Treatment
  • asked a question related to Medicine
Question
7 answers
Cure of cancer?, respectfully to whom it may concern:
If I found a cure of cancer, I’m wondering what I should do with it? I’m just coming out of a 40 days fast of only drinking maple syrup and pure lemon juice plus a little cinnamon powder and nothing else since I had unimaginable pain in my colon end. I figured out that although we humans can last for weeks on this diet /fast, cancer has no food on that and just goes away and the pain is gone too. I received this prescription by tuning in into the HeilstrOm and I figured out that it also enhances the reception of the HeilstrOm greatly, which brings great happiness too, as I describe in my book
Best regards, hope this helps someone
Chris K. Frueh
Independent Researcher
Relevant answer
Answer
@Seraphina Anderson good point
  • asked a question related to Medicine
Question
6 answers
Apollo Medicine is coming up with a special issue on Metabolic Syndromes.
Relevant answer
Answer
I will be glad to be the part of it
  • asked a question related to Medicine
Question
3 answers
I want to study medicine, become a doctor. What courses should I self-study?
Relevant answer
Answer
Then study pharmacy, there u get the most knowledge you need.
  • asked a question related to Medicine
Question
3 answers
How does Homeopathy Artificial Intelligence relate the Innovative Implications of AI's Revolutionary Role in Homeopathic Medicine?
Relevant answer
Answer
Artificial Intelligence (AI) is revolutionizing homeopathic medicine by enhancing the precision and personalization of treatments. AI algorithms can analyze vast amounts of patient data, including symptoms and medical history, to identify the most suitable homeopathic remedies more efficiently than traditional methods. Machine learning models detect patterns and correlations that may not be evident to practitioners, leading to more effective treatment plans. Additionally, AI facilitates remote consultations and real-time monitoring of patient progress. This integration of AI brings innovative implications by improving patient outcomes, streamlining clinical workflows, and advancing research within homeopathic medicine.
  • asked a question related to Medicine
Question
4 answers
Hello everyone,
Does anyone know of any research papers on experimental drug effect analysis using deep learning? If so, I would appreciate it if you could share the name or link with me. That would be greatly helpful.
Additionally, I would love to hear your thoughts on experimental drug effect analysis and what key points should be included when writing a paper on this topic, especially when I'm not allowed to share the dataset or details of the experiment itself.
Thanks in advance!
Relevant answer
Answer
Cell count and segmentation are essential in experimental drug effect analysis, providing both quantitative and qualitative insights. Cell counting helps assess changes in cell proliferation, growth, or death, offering a clear measure of a drug's efficacy or toxicity. Segmentation enables detailed visualization of individual cells, allowing researchers to study drug-induced changes in cell morphology, structure, and specific subcellular components. Additionally, segmentation aids in tracking cell populations and behaviors, such as movement and differentiation. Together, these techniques offer a comprehensive view of drug impacts on cellular dynamics, helping to optimize drug effectiveness, dosage, and identify potential side effects.
  • asked a question related to Medicine
Question
1 answer
MOST human actions are subconscious. The more close-ended the task, the easier to automate. Perhaps SOME subconscious human acts are more close-ended, therefore easier to automate.
Relevant answer
Answer
Automating biological functions such as childbirth with AI is a highly complex and ethically sensitive area. While AI can significantly enhance and assist in many aspects of healthcare, full automation of biological functions, especially something as intricate and personal as childbirth, presents numerous challenges and limitations. Here's a breakdown of how AI can be involved, and the specifics of its application:
1. Monitoring and Diagnosis
  • Fetal Monitoring: AI can analyze data from fetal heart rate monitors and ultrasound images to detect signs of distress or abnormalities.
  • Predictive Analytics: AI algorithms can predict potential complications during pregnancy by analyzing historical data and risk factors.
2. Assisting in Decision-Making
  • Clinical Decision Support: AI tools can provide recommendations for treatment options based on current medical guidelines and patient data.
  • Personalized Care: AI can help tailor prenatal care plans to individual needs by analyzing various health metrics.
3. Automation of Procedures
  • Surgical Assistance: AI-driven robotic systems, like the Da Vinci Surgical System, assist surgeons in performing precise operations, which can be beneficial in cesarean sections and other surgical procedures.
  • Lab Automation: AI can streamline lab processes related to prenatal care, such as genetic testing and analysis.
4. AI in Healthcare Management
  • Workflow Optimization: AI can improve hospital workflows, manage patient records, and ensure timely care delivery.
  • Patient Engagement: AI-powered chatbots and virtual assistants can provide patients with information, reminders, and support throughout their pregnancy.
5. Ethical and Practical Considerations
  • Complexity of Childbirth: Childbirth involves complex physiological and emotional factors that are challenging to fully automate or control with AI.
  • Ethical Issues: Automating biological functions raises significant ethical concerns about safety, consent, and the role of human judgment in critical medical situations.
  • Human Factors: Human expertise and empathy play a crucial role in managing childbirth, making it difficult to fully replace with AI.
Current State and Future Potential
  • Current Technology: While AI significantly aids in the management and support of childbirth, it does not replace the need for human intervention and decision-making. It can, however, enhance safety, efficiency, and personalized care.
  • Future Prospects: Advancements in AI may further assist in predictive analytics, personalized medicine, and robotic surgery, but the automation of biological functions like childbirth will remain a collaborative effort between technology and human expertise.
Summary
AI can enhance and support various aspects of childbirth and prenatal care, such as monitoring, decision-making, and procedure assistance. However, the full automation of childbirth involves complex physiological, ethical, and human factors that cannot currently be fully addressed by AI alone. AI’s role is to complement and support human expertise rather than replace it.
  • asked a question related to Medicine
Question
18 answers
In the identified case of familial desminopathy (T341P DES mutation in heterozygous state), the son has bradycardia, but the father did not have bradycardia. How can this fact be explained?
Relevant answer
Answer
Because of some autosomal dominant & others can be autosomal recessive
"Desminopathy is one of the most common intermediate filament human disorders associated with mutations in closely interacting proteins, desmin and alphaB-crystallin. The inheritance pattern in familial desminopathy is characterized as autosomal dominant or autosomal recessive, but many cases have no family history."
  • asked a question related to Medicine
Question
6 answers
What is the best solution for the dilemma between evidence-based medicine (EBM) for populations and for individuals, which arises from the tension between general recommendations based on population-level data and the need to tailor medical decisions to an individual’s unique circumstances? What percentage of people in your practice require tailored care?
Relevant answer
Answer
The dilemma between population-level evidence-based medicine (EBM) and individual patient care is a well-recognized challenge. The best solution often lies in a balanced, integrative approach:
  1. Shared Decision-Making (SDM): This approach combines the best available evidence with patient preferences and values. While EBM provides generalized guidelines, SDM allows for personalized care by actively involving the patient in the decision-making process.
  2. Clinical Judgment: Experienced clinicians use their expertise to interpret EBM in the context of individual patient characteristics (e.g., genetics, co-morbidities, lifestyle). They weigh the evidence but adapt it to the patient's unique situation.
  3. Precision Medicine: Advances in genomics, pharmacogenetics, and biomarkers are increasingly allowing care to be individualized based on a patient's specific biological makeup, rather than solely relying on population-level data.
  4. Risk Stratification: Some patients benefit from stratification into risk categories that inform how strictly EBM should be applied or adapted, depending on factors such as age, gender, ethnicity, or pre-existing conditions.
Regarding the percentage of people in practice who require tailored care, it varies by specialty and patient population, but many studies suggest that 30-40% of patients need some form of individualized adaptation of EBM guidelines, particularly those with complex medical conditions, multiple comorbidities, or unique genetic factors. This number can increase in more complex cases or specialized fields.
What is your experience regarding how often you need to tailor care to your patients?
  • asked a question related to Medicine
Question
2 answers
I am reaching out to seek your advice regarding an issue I have been experiencing with the journal of Annals of Medicine. Our manuscript was accepted on 19 April 2024, and the editorial board told us the proof would be sent to us within 48 hours. However, despite multiple follow-ups, we have yet to receive the proof until now. Each time we contact the journal, we are informed that my paper is undergoing an additional check.
We have try to contact the Taylor&Francis, which is the publication company of Annals of Medicine, many times, but they never reply us.
Has anyone else encountered a similar situation? If so, how did you manage to resolve it? Any advice or suggestions on how I might expedite this process or get a clearer response from the journal would be greatly appreciated.
Thank you in advance for your insights and assistance.
Relevant answer
Answer
It sounds frustrating to experience delays in receiving proofs from the Annals of Medicine, especially after receiving initial assurances. Here are some strategies you might consider to expedite the process and get clearer responses:1. Document Everything:
  • Keep a detailed record of all your communications with the journal, including dates, times, and the content of your messages. This documentation can be helpful if you need to escalate the issue.
2. Follow Up Regularly:
  • Continue to follow up with the journal at regular intervals. A polite but persistent approach can sometimes yield results. If you haven't already, consider varying your communication methods (e.g., email, phone calls) to see if one is more effective than the other.
3. Contact Higher Authorities:
  • If you are not receiving satisfactory responses from the editorial team, consider reaching out to higher authorities within the journal or the publishing company, Taylor & Francis. Look for contact information for the editorial board or the publisher's customer service.
4. Seek Peer Support:
  • Engage with colleagues or peers who may have published in the same journal. They might have experienced similar issues and could offer insights or contacts that could help you.
5. Utilize Social Media:
  • Sometimes, public inquiries on platforms like Twitter or LinkedIn can prompt a quicker response from journals. If you choose this route, ensure your message is professional and respectful.
  • asked a question related to Medicine
Question
3 answers
If then which medicine production and name of the medicine what's is that?
Relevant answer
Answer
Egg shell is mainly calciumcarbonate. Is that used as a medicine?
  • asked a question related to Medicine
Question
1 answer
What are the most pressing ethical concerns surrounding the use of genetic engineering in agriculture, medicine, and other fields?
Relevant answer
Answer
Genetic engineering, while offering transformative potential across various fields such as agriculture and medicine, raises several pressing ethical concerns. These concerns can be categorized into several key areas:
1. Animal Welfare and Rights
The genetic engineering of animals poses significant ethical dilemmas. While it may lead to advancements in medicine and agriculture, there are intrinsic ethical concerns regarding the welfare of genetically modified animals. Critics argue that even if animal welfare can be safeguarded, the very act of altering an animal's genetic makeup raises moral questions about the rights of these beings and the potential for suffering.
Moreover, the pursuit of profit in agricultural production through genetic engineering can lead to practices that prioritize economic gain over animal welfare.
2. Human Genetic Engineering
The ethical implications of human genetic engineering, particularly germline editing, are profound. This technology could potentially eliminate genetic disorders, but it also raises concerns about unforeseen consequences, such as long-term health effects on future generations who cannot consent to these modifications.
Additionally, there is a fear of creating a societal divide where only certain groups can access enhancements, leading to inequality.
3. Environmental Impact
In agriculture, the use of genetically modified organisms (GMOs) can have unintended environmental consequences. These include potential biodiversity loss and the risk of genetically modified traits spreading to wild populations, which could disrupt ecosystems. The ethical question here revolves around the responsibility of scientists and corporations to ensure that their innovations do not harm the environment or contribute to ecological imbalance.
4. Socio-Economic Disparities
The commercialization of genetic engineering technologies often leads to concerns about access and equity. There is a risk that these technologies will primarily benefit wealthy individuals or nations, exacerbating existing inequalities in health and food security. Ensuring that genetic engineering is accessible to all, regardless of socioeconomic status, is a critical ethical consideration.
5. Informed Consent and Autonomy
In the context of gene therapy, ethical issues arise regarding informed consent, especially when the subjects of genetic modifications are not yet born. This raises questions about autonomy and the rights of individuals who may be affected by genetic changes made by others. The ethical principle of respecting individual autonomy must be balanced against the potential benefits of genetic interventions.
Conclusion
The ethical landscape surrounding genetic engineering is complex and multifaceted. It requires ongoing dialogue among scientists, ethicists, policymakers, and the public to navigate these challenges responsibly. As genetic engineering continues to evolve, addressing these ethical concerns will be crucial to ensuring that its applications benefit society as a whole without compromising ethical standards.
  • asked a question related to Medicine
Question
2 answers
Relevant answer
Answer
Epigenetics refers to the study of changes in gene expression that do not involve alterations to the underlying DNA sequence. This field has garnered significant attention for its potential to influence aging, combat diseases, and mitigate unwanted side effects of genetic engineering.
Aging is associated with various epigenetic changes, such as DNA methylation and histone modifications, which can lead to altered gene expression and contribute to age-related diseases like cancer and neurodegenerative disorders. By targeting these epigenetic modifications, researchers believe it may be possible to reverse or slow down the aging process. For instance, interventions that modify epigenetic markers could potentially restore youthful gene expression patterns, thereby improving cellular function and longevity.
Epigenetic therapies hold promise for treating a range of diseases. By understanding the specific epigenetic alterations associated with conditions like cancer, researchers can develop targeted therapies that either activate or repress certain genes without changing the genetic code itself. This approach could lead to more effective treatments with fewer side effects compared to traditional genetic engineering methods, which often involve irreversible changes to the genomeOne of the significant concerns with genetic engineering is the potential for unintended consequences, such as off-target effects or the activation of harmful genes. Epigenetic modifications can provide a more flexible approach to gene regulation, allowing for temporary changes that can be reversed if necessary.
This flexibility could help in fine-tuning therapeutic interventions, reducing the risk of adverse effects associated with permanent genetic alterations.
  • asked a question related to Medicine
Question
5 answers
I was on line with famous nephrologist and come to know about kidneys treatment by allopathic medicine.
Then my question ❓ is kidney will get back normal' position.
Relevant answer
Answer
When it comes to treating kidney disease, particularly in the second stage of chronic kidney disease (CKD), both homeopathy and allopathy offer different approaches, and the effectiveness can vary based on individual circumstances.
Homeopathy is often touted for its potential to stimulate the body's immune system, which may help improve kidney function. Some practitioners claim that homeopathic treatments can lead to significant improvements in kidney health, potentially allowing patients to withdraw from dialysis or avoid more invasive treatments like transplantation. Homeopathy is believed to work by addressing the underlying causes of kidney issues and promoting overall health, which can be particularly beneficial for patients with conditions like diabetes and hypertension that complicate kidney disease
Allopathic medicine, which includes conventional treatments such as medications, dialysis, and kidney transplants, focuses on managing symptoms and preventing further damage to the kidneys. While allopathic treatments do not cure kidney disease, they can effectively manage the condition and prolong life by performing the essential functions of the kidneys.
For patients in the second stage of CKD, allopathic treatments may include medications to control blood pressure, manage diabetes, and reduce proteinuria, which can help slow the progression of kidney disease.
  • asked a question related to Medicine
Question
3 answers
Preparing a review about potential distinct effects of North and South poles (or upward/downward) in biology, chemistry, chirality, etc, I would appreciate any signaling of publications to supplement a databank dedicated to this overlooked parameter, whether confirming or invalidating.
Also, any comments, exchanges or collaboration will be welcome.
Relevant answer
Answer
Thank you for your answers but your replies don't really meet the topic whether there are distinct effects of what different research teams consider as:
- magnetic upward and downward fields (relative to gravity) effects,
- or only magnetic field direction (regardless of spatial orientation),
- or magnetic north and south polarities (by the way, note that many papers in English use reversed namings of the North and South poles of magnets!).
To help understand this discussion, here are examples of papers mentioning this side of the issue (whether positive or no effect):
- Life on Magnet: Long-Term Exposure of Moderate Static Magnetic Fields on the Lifespan and Healthspan of Mice
- Hematological parameters’ changes in mice subchronically exposed to static magnetic fields of different orientations
- Effect of pre-sowing treatment with permanent magnetic field on germination and growth of chilli
- Effects of Cholinergic Receptor Activation and Magnetic Fields on Motor Behavior in Ischemic Gerbils
- Magneto-mechanical stimulation modulates osteocyte fate via the ECM-integrin-CSK axis
- Homogeneous static magnetic field of different orientation induces biological changes in subacutely exposed mice
- Comparative effect of positive and negative static magnetic fields on heart rate and blood pressure in healthy adults
Thanks for your patience!
  • asked a question related to Medicine
Question
2 answers
European Society of Medicine sent an invitation for a special theme issue on COVID-19. Is this invitation genuine?
  • asked a question related to Medicine
Question
4 answers
📢 Call for Papers: New Asian Journal of Medicine, Volume 2 – Issue 2, 2024 📢 We are delighted to announce that the New Asian Journal of Medicine (NAJM) is now inviting submissions for our 2024 issues. In our commitment to advancing global medical knowledge, we are offering free publication for all articles accepted in 2024. Submission Deadline: 🗓️ July 31, 2024 Topics of Interest Include, But Are Not Limited To: Clinical Medicine Public Health Initiatives Medical Ethics Infectious Diseases Chronic Disease Management Medical Imaging Surgical Techniques Healthcare Policy Patient Safety and Quality Improvement Medical Education We welcome submissions from researchers across the globe, aiming to reflect the diverse nature of medical science and practice. Types of Submissions Accepted: Original Research Narrative Reviews Systematic Reviews Editorials Clinical Trials Perspectives Opinions Letters to the Editor Commentaries Submission Guidelines: All submissions must adhere to NAJM guidelines and are subject to a robust peer review process to maintain the highest standards of scholarly integrity and scientific excellence. How to Submit: Please submit your manuscripts through the NAJM online submission system at [https://nasianjmed.com/index.php/najm/announcement/view/2]. If you encounter any difficulties or have questions, contact our editorial office at [editor@nasianjmed.com].
Relevant answer
Answer
Can I upload original Research related to Dentistry ?
Thank you
  • asked a question related to Medicine
Question
4 answers
A new medicine PCSK9 inhibitor for lowering LDL has been developed.How does PCSK9 inhibitor differed from statin which has earlier been used s​i​nce many years to lower cholesterol levels in the blood.
Relevant answer
These are inhibitors of the PCSKexin and are used often in combination therapy to achieve target goals for lipid therapy. They are available in injection forms are their cost are very high at the moment.
  • asked a question related to Medicine
Question
2 answers
Over the past few years, there has been tremendous advancement in artificial intelligence (AI). Faculty from across the Yale Department of Internal Medicine are using AI as a tool to help improve the way they learn, teach, conduct research, and advance the field of medicine. “By using the power of AI, we are unlocking new opportunities to improve the way we conduct research and teach students—all with the ultimate goal of making health care better for our patients.”
source: Gary Désir, MD, Paul B. Beeson Professor of Medicine
Relevant answer
Answer
Dear Eduard Babulak , wouldn't an obvious (yet cheap, I know) answer be to point to the interests of food industry targeting children with unhealthy food? Don't know how relevant this is though.
Best Wishes,
Haris
  • asked a question related to Medicine
Question
2 answers
Relevant answer
Answer
Definitely yes
  • asked a question related to Medicine
Question
20 answers
I just had an email from the European Society of Medicine asking for a contribution to the journal Medical Research Archives. There is a similar journal on Cabell's published by KEI publishers, however I am unsure if this is the same journal. The European Society of Medicine from the website seems legit. Can anyone offer their personal experiences with the European Society of Medicine?
Relevant answer
Answer
Multiple emails from Medical Research Archives of the European Society of Medicine asked me to contribute. The editor is someone named L. Smith who is not mentioned anywhere online. At first, I ignored them but eventually, after repeated emails I said yes. After that they asked me to pay to contribute and graciously offered me a 15%discount when I said I couldn't.
This is a predatory journal that looks out for young researchers from developing countries who might be relatively more desperate to get published. My advice is to stay away from such journals. They are a scam.
Below is the email i received asking me to pay to contribute as if they are doing me a favor.
"
Thank you for your response. As an open-access journal with zero subscription or advertising revenue, we do have to charge a publication fee to keep the journal running. However, we do have some lower-priced options available.
Members of the society are exempt from the publication fees. Standard membership is $999 and reduced membership for developing countries is $499. This is the most economical option and includes 3 article publications per year. More details and the signup page may be found here.
Alternatively, if you don't want to go the membership route, I can offer a 15% discount on the regular publication fees. The discount code to enter on the registration form is ESMED23
Which of these options would work best for you?
Sincerely,
L. Smith
Chair of Editorial Committee
Medical Research Archives
European Society of Medicine
Online ISSN: 2375-1924
Print ISSN: 2375-1916
View on PubMed"
  • asked a question related to Medicine
Question
2 answers
Generally life extension and anti-aging. A lower death rate cancels out a low birthrate. https://www.researchgate.net/publication/382049802_Correcting_Cell_Errors
Relevant answer
Answer
This can be achieved by improving socioeconomic status of individual, and reduce economic hardshi.p
Reduce the depopulation strategies of contraceptive usage.
Frop the islamic point of view encourage polygamy where man is entitle to four wives provided he can cater for their well-being
  • asked a question related to Medicine
Question
7 answers
It is known that patients with desminopathy often die from pneumonia. Have pathomorphological studies of the lungs been performed in patients with desminopathy?
Relevant answer
Answer
Dear Sagar Nanaso Salunkhe, thank you very much for your detailed answers!
  • asked a question related to Medicine
Question
1 answer
The focus is on the lack of research for culturally tailored interventions to provide effective treatment for the NA/AN population. There are cultural barriers surround distrust, misinterpretation, disparities between Western medicine and traditional healing, and more.
Relevant answer
Answer
implicit bias is one reason; the other reason is lack of funding and educational resources
  • asked a question related to Medicine
Question
3 answers
I need materials on intersection between literature and medicine.
Relevant answer
Answer
The Plague (French: La Peste) is a 1947 novel by Albert Camus.
  • asked a question related to Medicine
Question
1 answer
I'd trying the several countries with several religions on young and older. what are which books so far. Sound Medicine, Music Medicine on many religions working now.
Relevant answer
Answer
All kind of music are good therapy according to the case response e.g classic is excellent for psychetric respose
  • asked a question related to Medicine
Question
2 answers
Respected researchers. Our team would be happy to work with anyone who is interested in contributing to the writing of a single review paper on veterinary homoeopathy. The collaborator ought to be sincere and have some writing experience in the scientific field or publishing. You can directly message me on ResearchGate or email me at dr.abrar79@gmail.com with a brief introduction about yourself.
Warm Regards
Dr. Abrar
Scientist, Department of Medicine
GADVASU, Ludhiana, Punjab
Relevant answer
Answer
I will help if you needed In Ayurved veterinary medicine review paper.
thanks for recommending me..
  • asked a question related to Medicine
Question
24 answers
Is the design of new pharmaceutical formulations through the involvement of AI technology, including the creation of new drugs to treat various diseases by artificial intelligence, safe for humans?
There are many indications that artificial intelligence technology can be of great help in terms of discovering and creating new drugs. Artificial intelligence can help reduce the cost of developing new drugs, can significantly reduce the time it takes to design and create new drug formulations, the time it takes to conduct research and testing, and can thus provide patients with new therapies for treating various diseases and saving lives faster. Thanks to the use of new technologies and analytical methods, the way healthcare professionals treat patients has been changing rapidly in recent times. As scientists manage to overcome the complex problems associated with lengthy research processes, and the pharmaceutical industry seeks to reduce the time it takes to develop life-saving drugs, so-called precision medicine is coming to the rescue. It takes a lot of time to develop, analyze, test and bring a new drug to market. Artificial intelligence technology is particularly helpful in this regard, including reducing the aforementioned time to create a new drug. When creating most drugs, the first step is to synthesize a compound that can bind to a target molecule associated with the disease. The molecule in question is usually a protein, which is then tested for various influencing factors. In order to find the right compound, researchers analyze thousands of potential candidates of different molecules. When a compound that meets certain characteristics is successfully identified, then researchers search through huge libraries of similar compounds to find the optimal interaction with the protein responsible for the specific disease. In contrast, many years of time and many millions of dollars of funding are required to complete this labor-intensive process today. In a situation where artificial intelligence, machine learning and deep learning are involved in this process, then the entire process can be significantly reduced in time, costs can be significantly reduced and the new drug can be brought to the pharmaceutical market faster by pharmaceutical companies. However, can an artificial intelligence equipped with artificial neural networks that has been taught through deep learning to carry out the above-mentioned processes get it wrong when creating a new drug? What if the drug that was supposed to cure a person of a particular disease produces a number of new side effects that prove even more problematic for the patient than the original disease from which it was supposed to be cured? What if the patient dies due to previously unforeseen side effects? Will insurance companies recognize the artificial intelligence's mistake and compensate the family of the deceased patient? Who will bear the legal, financial, ethical, etc. responsibility for such a situation?
I described the key issues of opportunities and threats to the development of artificial intelligence technology in my article below:
OPPORTUNITIES AND THREATS TO THE DEVELOPMENT OF ARTIFICIAL INTELLIGENCE APPLICATIONS AND THE NEED FOR NORMATIVE REGULATION OF THIS DEVELOPMENT
In view of the above, I address the following question to the esteemed community of scientists and researchers:
Is the design of new pharmaceutical formulations through the involvement of AI technologies, including the creation of new drugs to treat various diseases by artificial intelligence, safe for humans?
Is the creation of new drugs by artificial intelligence safe for humans?
What do you think about this topic?
What is your opinion on this issue?
Please answer,
I invite everyone to join the discussion,
Thank you very much,
Best wishes,
Dariusz Prokopowicz
The above text is entirely my own work written by me on the basis of my research.
In writing this text I did not use other sources or automatic text generation systems.
Copyright by Dariusz Prokopowicz
Relevant answer
Answer
Why AlphaFold 3 Needs to Be Open Source
The powerful AI-driven software from DeepMind was released without making its code openly available to scientists...
"IMAGINE A WORLD where in a matter of minutes, scientists could identify drugs to treat incurable diseases, design chemicals that could break down plastics to clean up pollution, and develop new materials that can suck excess carbon dioxide out of the air to help address climate change. This is the promise of new biology- and chemistry-based models that use artificial intelligence, or AI, to perform traditionally time-consuming tasks such as determining the structures of proteins.
Google DeepMind, a private research subsidiary of Google, released the highly anticipated AlphaFold 3 model last month as a paper in Nature. This model claims to be an improvement over its earlier version, AlphaFold 2, because it can predict not just protein structures, but also how they interact with RNA, DNA, and — most importantly — drugs. DeepMind said that it hopes AlphaFold 3 will “transform our understanding of the biological world and drug discovery.”...
In an editorial response published on May 22, Nature claimed that by allowing peer-reviewed publications from the private sector, it “promotes the sharing of knowledge, verification of the research and the reproducibility researchers strive for” and that its policy states that the editors reserve the right to decide if all code needs to be released. However, it’s unclear to me how one can verify research without having the tools available to do so..."
  • asked a question related to Medicine
Question
1 answer
What factors contribute to the value of a review article, and
how is this value related to scientific criteria?
Relevant answer
  • asked a question related to Medicine
Question
2 answers
Can you explain the process involved in preparing a
systematic review, as outlined in the article?
Relevant answer
  • asked a question related to Medicine
Question
1 answer
What is the PRISMA statement, and how does its checklist
help in structuring a review article?
Relevant answer
  • asked a question related to Medicine
Question
2 answers
How is a research question typically formulated in the
context of review articles, and what is the significance of
using the PICO format?
Relevant answer
  • asked a question related to Medicine
Question
1 answer
How does the hierarchy of evidence help in assessing the
quality of studies based on different research questions?
Relevant answer
  • asked a question related to Medicine
Question
2 answers
A reviewer is needed for a WOS journal with general medicine topics.
should be at least an associate professor.
Relevant answer
Answer
I HAVE.
  • asked a question related to Medicine
Question
2 answers
Inflation of unqualified unv-diplomas cause unemployment among graduates. Children of high social statue families most will be employed ! While others, most will be unemployed or underemployed. With board exams not only graduates but also universities will also be objectively classified for their BA/BS.
Relevant answer
Answer
  1. Degree Inflation: It's true that the value of a BA/BS degree may be perceived as diminishing over time due to the increasing number of individuals obtaining these degrees. This can lead to what is often referred to as "degree inflation," where a bachelor's degree becomes less of a distinguishing factor in the job market.
  2. Unemployment: While a BA/BS degree is still a significant milestone and can open doors to many career opportunities, the unemployment rate for recent graduates can be influenced by various factors, including economic conditions, the job market's demand for specific skills, and the individual's preparedness for the workforce.
  3. National Board Exams: In professions like medicine, pharmacy, dentistry, and law, rigorous national board exams are required after graduation to ensure that graduates meet a certain standard of competence. These exams are a form of quality control that helps maintain the integrity and reputation of the profession.
  • asked a question related to Medicine
Question
12 answers
Dear colleagues,
I have received an invitation to the Global Conference on Development in Medicine, Science, and Education (GCDMSE - 2024), but I need to find out the organizers. Does anyone know more and can provide me with information, experiences and the like? Thanks a lot and best regards
Ottomar Bahrs
Relevant answer
Answer
Hi Dr. Ottomar
I received an email about this conference; please let me know if someone has answered you or provided you with the info. Thanks
  • asked a question related to Medicine
Question
6 answers
📢 Call for Papers: New Asian Journal of Medicine, Volume 2 – Issue 2, 2024 📢 We are delighted to announce that the New Asian Journal of Medicine (NAJM) is now inviting submissions for our 2024 issues. In our commitment to advancing global medical knowledge, we are offering free publication for all articles accepted in 2024. Submission Deadline: 🗓️ July 31, 2024 Topics of Interest Include, But Are Not Limited To: Clinical Medicine Public Health Initiatives Medical Ethics Infectious Diseases Chronic Disease Management Medical Imaging Surgical Techniques Healthcare Policy Patient Safety and Quality Improvement Medical Education We welcome submissions from researchers across the globe, aiming to reflect the diverse nature of medical science and practice. Types of Submissions Accepted: Original Research Narrative Reviews Systematic Reviews Editorials Clinical Trials Perspectives Opinions Letters to the Editor Commentaries Submission Guidelines: All submissions must adhere to NAJM guidelines and are subject to a robust peer review process to maintain the highest standards of scholarly integrity and scientific excellence. How to Submit: Please submit your manuscripts through the NAJM online submission system at [https://nasianjmed.com/index.php/najm/announcement/view/2]. If you encounter any difficulties or have questions, contact our editorial office at [editor@nasianjmed.com].
Relevant answer
Answer
We are working to index it inScopus, and after that in PubMed. We are working hard......
  • asked a question related to Medicine
Question
8 answers
Hello
Are diuretic medicine, thiazide type
Inhibits Na absorption from DCT or PCT?
Relevant answer
Answer
Work through inhibition of Na reabsorbtion at DCT
  • asked a question related to Medicine
Question
7 answers
Has medicine become a trade and not a humanitarian profession, but rather a commercial and investment profession?
Relevant answer
Answer
Profiteering-from-disease Rasha A Waheeb has become the standard model of the medical profession, i.e. the disease-centered model of treatment (mainly drugs and surgery) is consequently a low empathy model, based on monetary profit.
It has to be mentioned here that treatment and healing are not the same; there exist other practical models for the medical profession, e.g. person-centered health care, integral health care, but the physician is always part of a society, i.e. certain working conditions, e.g. highly industrialized medical institutions.
Data on the health of health of (our) physicians are also alarming, i.e. the whole machinery comes with a price to pay, not only for the patients.
Conclusion:
A change in perspective is a must. As long as ‘modern medicine’ adheres to the tenets of ‘classical science’, subjects will be regarded as objects, consciousness will be reduced to (DNA) matter, and living beings as cadavers. This is not a figure of speech. Medical students still spend much time studying cadavers; without considering how this alienates them from contact with living beings.
Modern medicine manipulates politicians and the public by referring to the merits of classical science. Classical science is a deadly foundation for health care ! Classical science addressed invariance: action + reaction=0///No-change).Invariance was traditionally called Hell (closed system).
Modern’ medicine uses the philosophy of mechanical material control and domination (a war model) to overrule all ‘other’ forms of healing.
Few people (and fewer doctors) are aware how the medical model is crippled by ‘belief’ in classical science. The mechanistic material model is associated with control and mass production; it was developed for (and from) the study of inert matter. Living beings are thereby regarded by the mechanical material ‘laws of inertia/dead matter’.
Since 1900 science underwent drastic changes, not matter, but information is now the essence. The focus shifted from (classical, material) matter of physics, to (relativistic, molecular) chemical processes, to (probabilistic, atomic) electromagnetic interactions, and now to (phase-field) information integrity. All of these considerations can be recognised in the living being; but still need to be included in the classical medical model.
  • asked a question related to Medicine
Question
6 answers
Can you provide examples of how evidence-based medicine has positively impacted patient outcomes or healthcare practices?
Relevant answer
Answer
Evidence-based medicine (EBM) has had a significant positive impact on patient outcomes and healthcare practices across various clinical specialties. Here are some examples:
  1. Reduction in Mortality and Morbidity: Implementation of evidence-based guidelines and protocols for acute myocardial infarction (heart attack) management, such as timely administration of aspirin, thrombolytics, and percutaneous coronary intervention (PCI), has led to significant reductions in mortality rates and complications associated with myocardial infarction.
  2. Improved Cancer Screening and Treatment: Evidence-based screening guidelines for breast, colorectal, cervical, and prostate cancers have increased early detection rates, leading to earlier diagnosis, more effective treatment interventions, and improved survival outcomes for patients with cancer.
  3. Prevention of Healthcare-associated Infections: Adherence to evidence-based infection prevention and control practices, such as hand hygiene protocols, aseptic techniques, and appropriate use of antimicrobial agents, has resulted in reductions in healthcare-associated infections (HAIs) and related morbidity and mortality rates in hospitals and healthcare facilities.
  4. Enhanced Surgical Outcomes: Adoption of evidence-based surgical practices, including preoperative optimization, surgical checklists, enhanced recovery after surgery (ERAS) protocols, and minimally invasive surgical techniques, has led to improvements in surgical outcomes, shorter hospital stays, and reduced postoperative complications for patients undergoing surgery.
  5. Management of Chronic Diseases: Evidence-based management strategies for chronic diseases such as diabetes, hypertension, asthma, and chronic obstructive pulmonary disease (COPD) have improved disease control, reduced disease progression, and prevented complications, resulting in better quality of life and health outcomes for patients with chronic conditions.
  6. Reduction in Medication Errors: Implementation of evidence-based medication reconciliation processes, computerized physician order entry (CPOE) systems, clinical decision support tools, and pharmacist-led medication therapy management programs has helped reduce medication errors, adverse drug events, and medication-related hospitalizations.
  7. Promotion of Patient Safety and Quality Improvement: Integration of evidence-based patient safety practices, such as standardized protocols for handoffs and communication, checklists for surgical procedures, and root cause analysis of adverse events, has contributed to improvements in patient safety culture, reduction in medical errors, and enhancement of healthcare quality and reliability.
  8. Optimization of Maternal and Neonatal Health: Evidence-based practices in obstetrics and neonatology, such as antenatal screening, intrapartum monitoring, use of evidence-based protocols for labor induction and cesarean section, and implementation of neonatal resuscitation guidelines, have improved maternal and neonatal outcomes, reduced maternal and infant mortality rates, and enhanced perinatal care.
Overall, evidence-based medicine has revolutionized healthcare practices by providing clinicians with the tools, knowledge, and guidelines needed to deliver high-quality, patient-centered care, improve clinical outcomes, and enhance patient safety and satisfaction across diverse clinical settings and patient populations.
  • asked a question related to Medicine
Question
1 answer
How does evidence-based medicine help clinicians make informed decisions about patient care?
Relevant answer
Answer
Evidence-based medicine (EBM) helps clinicians make informed decisions about patient care by integrating the best available research evidence with clinical expertise and patient values and preferences. Here's how EBM facilitates informed decision-making:
  1. Access to Best Available Evidence: EBM emphasizes the importance of using the best available evidence from high-quality research studies, such as randomized controlled trials (RCTs), systematic reviews, and meta-analyses, to inform clinical practice. Clinicians have access to a wealth of evidence-based resources, including medical journals, clinical practice guidelines, online databases, and evidence summaries, to stay updated on the latest research findings and treatment recommendations.
  2. Critical Appraisal of Evidence: EBM equips clinicians with skills for critically appraising research evidence to assess its validity, relevance, and applicability to clinical practice. Clinicians evaluate the methodological quality, study design, outcome measures, statistical analysis, and potential sources of bias in research studies to determine the strength of evidence supporting specific interventions or treatments.
  3. Integration of Clinical Expertise: EBM recognizes the importance of clinical expertise and judgment in interpreting research evidence and applying it to individual patient cases. Clinicians integrate their knowledge of pathophysiology, diagnostic reasoning, therapeutic options, and patient preferences with the best available evidence to make personalized and context-specific decisions about diagnosis, treatment, and management.
  4. Consideration of Patient Values and Preferences: EBM emphasizes the importance of considering patient values, preferences, goals, and priorities in shared decision-making. Clinicians engage patients in meaningful discussions about treatment options, risks, benefits, uncertainties, and realistic expectations for outcomes, empowering them to make informed choices that align with their values and preferences.
  5. Promotion of Evidence-Based Practice Guidelines: EBM supports the development and dissemination of evidence-based clinical practice guidelines, which synthesize research evidence, expert consensus, and patient input to provide recommendations for optimal patient care. Clinicians use practice guidelines as a framework for decision-making, treatment planning, and quality improvement initiatives, ensuring consistency and standardization of care across healthcare settings.
  6. Continuous Learning and Improvement: EBM fosters a culture of lifelong learning and professional development among clinicians, encouraging them to stay updated on the latest evidence, guidelines, and advances in their field. Clinicians participate in continuing education activities, journal clubs, case discussions, and quality improvement projects to enhance their knowledge and skills in evidence-based practice.
  7. Evaluation of Treatment Effectiveness and Outcomes: EBM enables clinicians to evaluate the effectiveness, safety, and outcomes of interventions in real-world clinical practice. Clinicians monitor patient responses to treatment, assess adherence to evidence-based guidelines, and collect data on clinical outcomes and quality indicators to inform continuous quality improvement efforts and optimize patient care.
By incorporating principles of evidence-based medicine into clinical practice, clinicians can make informed decisions that are grounded in the best available evidence, aligned with clinical expertise and judgment, respectful of patient values and preferences, and conducive to improving patient outcomes and healthcare quality.
  • asked a question related to Medicine
Question
1 answer
What are the different levels of evidence in evidence-based medicine, and how are they categorized?
Relevant answer
Answer
Evidence-based medicine (EBM) utilizes various levels of evidence to guide clinical decision-making, with each level representing the strength of evidence supporting a particular intervention or practice. These levels are commonly categorized using a hierarchical framework, such as the one proposed by the Oxford Centre for Evidence-Based Medicine (OCEBM). Here are the different levels of evidence in EBM, categorized from the highest to lowest level:
  1. Level 1: Systematic Reviews and Meta-Analyses: Systematic reviews and meta-analyses of randomized controlled trials (RCTs) represent the highest level of evidence in EBM. These studies systematically gather, critically appraise, and synthesize existing research evidence on a specific clinical question or topic. Meta-analysis combines data from multiple RCTs to provide a quantitative summary of treatment effects, enhancing the precision and reliability of the findings.
  2. Level 2: Randomized Controlled Trials (RCTs): RCTs are experimental studies in which participants are randomly assigned to different treatment groups to evaluate the efficacy and safety of interventions. RCTs are designed to minimize bias and confounding factors, allowing for causal inference regarding the effects of interventions. Well-designed RCTs with appropriate randomization, blinding, and control groups provide high-quality evidence for clinical decision-making.
  3. Level 3: Cohort Studies: Cohort studies are observational studies that follow a group of individuals over time to assess the association between exposure to risk factors or interventions and the development of outcomes. Cohort studies provide valuable information about the natural history of diseases, the etiology of conditions, and the long-term effects of interventions. Prospective cohort studies, in which participants are followed forward in time, are considered stronger evidence than retrospective cohort studies.
  4. Level 4: Case-Control Studies: Case-control studies are observational studies that compare individuals with a particular outcome (cases) to those without the outcome (controls) to investigate potential risk factors or exposures associated with the outcome. While case-control studies are useful for exploring associations between exposures and outcomes, they are prone to biases such as recall bias and selection bias, which limit their ability to establish causality.
  5. Level 5: Case Series and Case Reports: Case series and case reports describe the clinical characteristics, management, and outcomes of individual patients or a small group of patients with a particular condition or intervention. While case series and case reports provide valuable insights into rare or novel conditions, treatments, or adverse events, they are considered low-level evidence due to their descriptive nature and lack of comparison groups.
  6. Level 6: Expert Opinion and Consensus Statements: Expert opinion and consensus statements represent the lowest level of evidence in EBM and are based on the collective judgment and expertise of clinical experts in the field. While expert opinion and consensus statements provide valuable clinical guidance in the absence of empirical evidence, they are susceptible to bias and may vary depending on the opinions and perspectives of individual experts.
It's important to note that the hierarchy of evidence is not absolute, and the appropriateness of evidence depends on the specific clinical question, context, and available resources. In practice, healthcare providers often integrate evidence from multiple levels to inform clinical decision-making and provide the best possible care for their patients.
  • asked a question related to Medicine
Question
3 answers
I'm a current medicine student and I'm in my first scientific initiation in my graduation. Currently, me and my professor are having some troubles with contamination in our cells. This is a bottle with HCT-116 cells (colorretal cancer). This cells were, previously frozen with contaminated fetal bovine serum. My professor said she thought she treated the cells, but this contamination keep returning. We supplement our media with penicilin and B- anfotericin at 1% each. The weird thing is: The bottle keeps healthy and, suddenly, from one day to another, these clouds appears and the bottle liquid looks cloudy. Could anyone, please, help me by advising what could I do or what fungus is this (If this is a fungus)?
Relevant answer
Answer
It is extremely difficult to completely eliminate bacteria from contaminated cells, and the contamination can return. Many labs have HCT116 cells. Therefore, if your cells are not invaluable (transfected for example), the best thing to do is to throw away your culture and request the cell line from a nearby lab.
  • asked a question related to Medicine
Question
7 answers
Most of the researchers use to teach at university. In some careers, professionals who exert their profession without doing research share teaching spaces. When I was a chemistry student, 100% of my teachers were researchers ranging from PhD candidates to experts in their respective fields. While it may seem logical for researchers to be the best candidates to teach in fields such as chemistry or biology, what about healthcare-related fields like medicine, pharmacy, or biochemistry? Who is better suited to lead a class, a researcher or a professional, or both, each one in different subjects? We can distinguish between basic and clinical subjects. I am interested in hearing your thoughts on this matter.
Relevant answer
Answer
Being a proficient researcher doesn't necessarily equate to being a better professor. While research expertise can enhance teaching by bringing current knowledge and real-world applications into the classroom, effective teaching requires distinct skills such as communication, empathy, and the ability to engage students.
A good professor balances both research and teaching responsibilities, tailoring their approach to meet the needs of their students while contributing to their field through research. However, being a successful researcher doesn't guarantee effective teaching, as teaching requires its own set of abilities and dedication.
  • asked a question related to Medicine
Question
4 answers
I have reviewed multiple health literacy instruments. The most popular are REALM, TOFHLA, Newest Vital Sign (NVS), and HLS-EU-Q (and their modifications/lingual adaptations).
I've noticed that health literacy tests were mostly focused on reading and numeracy skills. However, there are multiple aspects of health literacy, including noticing/tracking symptoms, remembering and applying newly-acquired medical knowledge, patient's capability of discussing (or sometimes arguing) with a doctor or insisting on taking some tests. Of course, it is not possible to measure all of the aspects of health literacy given the shortage of time for healthcare personnel.
I would appreciate it if you share some methods or techniques you use to understand a patient's health literacy (or identify low-literate patients).
Relevant answer
Answer
Hi Lucy,
Thank you for your reply. What kind of tools do mean?
I found one proposed by Barry D. Weiss (Health Literacy and Patient Safety: Help Patients Understand. Manual for Clinicians. 2nd ed.). The method is called "brownbag medication review.". Weiss proposes to ask a patient to bring all medications that they take on their visit. When the patient comes, a doctor or nurse should conduct the medication review where the patient should name each medication and explain the reason why they take it and how to take it.
Do you know other multi-modal methods of health literacy measuring?
  • asked a question related to Medicine
Question
1 answer
Do traditional healers rely on their medicine if they are sick of they do go to clinic/hospitals
Relevant answer
Answer
See my research on "non traditional healing in a psychiatric setting" for more details if interested. In my study, Santeria/Espiritismo, etc. the medical providers ended up using these services as well as their own. It became an integrated thoughtful system of healers.
  • asked a question related to Medicine
Question
1 answer
The causes of the medicine?
how effective it is on humans?
how it is made?(i.e how is the medicine made? what are the components used to make it?)
total info about its
Relevant answer
Answer
Present IBS-D medications work effectively by targeting various aspects of the condition. These medications often include antispasmodics to alleviate abdominal pain and cramping, anti-diarrheal agents to reduce bowel movements, and medications that modulate gut motility and serotonin levels to regulate bowel function. Additionally, dietary modifications and lifestyle changes are often recommended alongside medication to manage symptoms effectively. These medications aim to improve the quality of life for individuals with IBS-D by reducing symptom severity and frequency.
  • asked a question related to Medicine
Question
2 answers
please give me feedback about this journal...Plos Medicine?
I want to publish my first year phd research work in high impact factor I dont know i will be succeeded or not but i just want to try. Though my study is very simple but i just practiced and got some results
Relevant answer
Answer
The journal “PLOS Medicine” is a highly reputed journal in the field of medicine. Their impact factor 2023 (15.8) is high. So, by itself it is a safe choice. However, I see a number of problems:
-I estimate that they only accept manuscripts with significant impact (and a certain degree of urgency)
-The fee is (ridiculously) high 6300 USD https://plos.org/publish/fees/
-Looking at what you said yourself (my study is ‘very simple’ and the results are limited) I think it is not worth the try since the chances of success are slim to none
I think you should either extent the study or go for a somewhat more modest approach. There are numerous journals out there that can serve your purpose (getting your first research results published). Go for example to SCImago https://www.scimagojr.com click on Journal rankings and select Medicine (and select further for example neurology) then you end up with numerous suggestions. Personally, I would scroll down to Q2 and further (and be sure there are more than enough journals which might not be high impact journals but are just fine and more than just fine).
Best regards.
PS. Take for example https://www.sciencedirect.com/journal/journal-of-the-neurological-sciences here you can choose the open access option (but with a pretty hefty fee) or decline this option and go for the so-called subscription-based option (which is just fine for a first publication published by a well-known publisher that a large majority of researcher can access through their institutional license).
  • asked a question related to Medicine
Question
3 answers
I've attached two images. One has Elsevier's name on the journal's cover and Wolters Kluwer's on the other.
Relevant answer
Answer
Dear Koushik Majumder According to https://www.sciencedirect.com/journal/annals-of-medicine-and-surgery the journal is no longer hosted/owned by Elsevier (since 2023).
  • asked a question related to Medicine
Question
2 answers
a
Coco G. WTClub Commemorative
GRAND PRESIDENTIAL COMMEMORATIVE.
*President Bill Clinton *President Barrack Obama & *President Joseph Biden & VP Kamala Harris. *Historical Black Colleges* * Wilberforce University Xenia, Ohio. (ALUMNI) * * Black Farmers History Heritage Month * * 30 Years VOTE Democracy Grand Commemorative *
Bill Gates & Melinda Gates Foundation.
www. Azure Arc cloud; www. Azure Internet.com; Ai; Multi cloud Server applications; www.
NCBI.nlm.NIH.GOV/UNICEF/UN; ml; Hybrid Cloud; THINKSPEAK; Smart Lagos Arsenic
Water Quality Research Metals (SLAWQRM APP) Model Applications; (IaaS) (PaaS) (SaaS);
Microsoft Corporation GlobaI Pediatrics Health Care; Abort Medical Services Corporation; Planned Parenthood of Milwaukee, WI.
Https://www.ncbi.nlm.nih.gov/UNICEF.UN/ Mortality and Primary Causes of Death in
Mothers of Children / NIH / National Library of Medicine / (IaaS) (SaaS) Digital Output; (D) (Qin) flow; impacting Model (IaaS) Community. (PaaS) Maternal Healthcare. (PaaS) Satellite.
(SaaS) Clinics. (CMHSC). (Shared Networking);
STEAKHOLDERS
*Microsoft Global Health Specialist Rx; Care*
*Children Infant Pedialyte Supplements*
*Azure Aquatic Intelligence (TV) Awareness*
GET INVOLVE SUMMIT.
Pedialyte Water Dehydration; Outdoor Sports, Swimming and Fisheries (pH.) Toxicity Recreations Technical Proposal.
(IaaS) (PaaS) (SaaS)Digital Output; (D) (Qin) flow; to Smart (PaaS) Lagos State (SaaS) Arsenic Water Quality (Shared Networking) Research Metals (SLAWQRM APP) Model Applications; (IaaS) (PaaS) (SaaS) Online (AQUATIC AZURE WETLANDS Television (TV).
(SaaS)
impacting Metalliferous Contaminants Pollutant Effluent Events Systems; (SaaS) Digital Output; (D) (Qin) flow; to Coastal Federal highway’s flash waves flooding’s; dynamic cyclical riverine fate conveyor, transportation (Qin) flow; to Local Government Council Area roadway’s Storms Water Runoff; Pollutants Monitoring & Management Systems;(SaaS) Digital Output; (D) (Qin) flow; to
📷
(HRH) King of Lagos – Kabiyesi “Olu of Eko” Oba Rilwan Akiolu
Impacting Midstream (SaaS) Digital Output; (D) (Qout) flow; to and in to YEWA River (SaaS)
Digital Output; (D) (Qout) flow; to OLOGE River (SaaS) Digital Output; (D) (Qout) flow; to OGUN River (SaaS) Digital Output; (D) (Qout) flow; to OSHUN River (SaaS) Digital Output; (D) (Qout) flow; to Midstream (IaaS)(PaaS) (SaaS)(Shared Networking);
📷 Aleia Hobbs World Fastest 400Meter Hurdle
📷 📷
📷
Https://www.ncbi.nlm.nih.gov.unicef.un/ Mortality and Primary Causes of Death in Mothers of
Children. / NIH / National Library of Medicine / impacting Model (IaaS) Community. (PaaS)
Maternal Healthcare. (PaaS) Satellite. (SaaS) Clinics. (CMHSC). (SaaS) (Shared Networking);
Relevant answer
Answer
Buenas tardes. Experiencia: logré asignar un DOI en preprint en Research Gate siguiendo los pasos de ésta plataforma para unos de los artículos de los estudiantes, esperamos tener obervaciones en la plataforma. No la obtuvimos, así que lo postulamos para la publicación en una revista de nuestro medio, en la cual siguió el proceso normal de revisión de pares para la publicación con lo cual se asignó un DOI final.
Me queda la duda si debemos eliminar el DOI inicial del preprint de Research Gate y eliminar los archivos de ésta plataforma y unicamente presentar el DOI y versión final de la publicación en la revista.
Saludos cordiales
  • asked a question related to Medicine
Question
11 answers
A patient with desminopathy (mutation Thr341Pro DES in a heterozygous state) with the progression of the disease has a decrease in taste and smell, immunosuppression, and an increase in IgA in the blood.
Oddly enough, but all this is characteristic of infections, including viral ones. For example, it is known that if the hepatitis C virus is not treated, then death will occur in 20 years.
In the identified case of late onset desminopathy, muscle weakness manifests itself at the age of 30, and death occurs 20 years after the onset of the disease.
Could the desmin mutation in myofibrillar myopathy be caused by an infection?
Perhaps the infection contributes to the progression of desminopathy?
Relevant answer
Answer
Dear Esteemed Colleague,
Greetings. I trust this message finds you deeply engaged in your research and seeking answers to complex questions within the realm of genetics and molecular pathology. Your inquiry regarding the potential role of infection in causing desmin mutations in myofibrillar myopathy is both intriguing and indicative of a keen scientific mind exploring the multifaceted nature of genetic disorders.
To address your question with the precision and clarity it deserves, it is crucial to first understand the nature of myofibrillar myopathies and the role of desmin within this context. Myofibrillar myopathies are a group of neuromuscular disorders characterized by the progressive weakening of muscles and the disintegration of muscle fibers at a cellular level. Desmin, a type of intermediate filament protein, plays a pivotal role in maintaining the structural integrity and function of muscle cells. Mutations in the DES gene, which encodes the desmin protein, are directly linked to certain forms of myofibrillar myopathy.
The genesis of these mutations, particularly those affecting the desmin protein, is primarily genetic, resulting from inherited or de novo mutations in the DES gene. These mutations lead to the production of an abnormal desmin protein, which disrupts the normal architecture of muscle cells, leading to the symptoms associated with myofibrillar myopathy.
Addressing the specific question of whether an infection could cause desmin mutations, it is essential to differentiate between the origins of genetic mutations and factors that may exacerbate the phenotype of a genetic disorder. Genetic mutations, including those affecting the desmin gene, arise from alterations in the DNA sequence. These alterations can be inherited from parents, occur spontaneously during DNA replication, or be induced by certain environmental factors, such as exposure to specific chemicals or radiation. Infections, while capable of causing a wide array of health issues, do not directly induce genetic mutations in the DNA sequence of the genes like DES. However, it is conceivable that certain infections could exacerbate the clinical manifestations of myofibrillar myopathy in individuals already predisposed or carrying a desmin mutation, by stressing the muscular system or triggering inflammatory responses that may further compromise muscle function.
In conclusion, while infections can have significant impacts on overall health and may interact in complex ways with genetic disorders, the mutations in the DES gene that cause myofibrillar myopathy are not directly caused by infections. The mutations are genetic in origin, and the relationship between infections and the severity or progression of myofibrillar myopathy would be more accurately viewed through the lens of infection exacerbating pre-existing conditions rather than causing the genetic mutation itself.
I hope this elucidation addresses your inquiry comprehensively. Should you have further questions or require additional clarification, please feel free to reach out.
Warm regards.
This protocol list might provide further insights to address this issue.
  • asked a question related to Medicine
Question
4 answers
Dear Colleagues,
Academic Medicine & Surgery is accepting manuscripts that span the breadth and depth of medicine and surgery. FREE to publish, turnaround time is ~2 weeks. Article types accepted include original research, practice innovations, data notes, technical notes, clinical images, case reports, and survey studies.
Relevant answer
Answer
Latha Ganti - Starting a new medical publisher and journal is a difficult enterprise, I do have some questions for you:
- Will the journal have Volumes or will you add the year to serve as a volume number?
- Who is the Editor, managing editor, etc.?
- Do you have any indexing and archiving sources? (I did find an article on scholar.google)
- Will you have a current issue page and an archives page?
  • asked a question related to Medicine
Question
1 answer
How can we improve computer-brain interfaces for broader and safer use in medicine, research, and daily life?
Relevant answer
Answer
Improving computer-brain interfaces (CBIs) for broader and safer use in medicine, research, and daily life requires advancements in several key areas. Here are some strategies to enhance CBIs:
  1. Biocompatibility and Safety: Develop CBIs with materials and components that are biocompatible and pose minimal risk of tissue damage or immune response. This involves research into novel materials, coatings, and fabrication techniques to ensure safe and long-term integration with the brain.
  2. Minimally Invasive Techniques: Explore minimally invasive approaches for implanting CBIs, such as flexible electrodes, micro-scale devices, or non-invasive methods like transcranial magnetic stimulation (TMS) or electroencephalography (EEG). Minimizing tissue damage and surgical trauma can improve patient outcomes and acceptance of CBIs.
  3. High Spatial and Temporal Resolution: Enhance the spatial and temporal resolution of CBIs to enable precise and real-time monitoring and modulation of brain activity. This involves advancements in electrode design, signal processing algorithms, and imaging technologies to capture neural activity with high fidelity.
  4. Closed-Loop Systems: Develop closed-loop CBIs that can dynamically adapt stimulation parameters or therapeutic interventions based on real-time feedback from neural signals. Closed-loop systems can optimize treatment efficacy, minimize side effects, and improve patient outcomes in conditions such as epilepsy, Parkinson's disease, and chronic pain.
  5. Wireless and Wearable Interfaces: Design wireless and wearable CBIs that offer convenience, portability, and ease of use for patients and researchers. Wireless interfaces eliminate the need for cumbersome cables and connectors, enabling greater mobility and flexibility in clinical and research settings.
  6. User-Friendly Interfaces: Create user-friendly interfaces and software tools that simplify interaction with CBIs for both clinicians and end-users. Intuitive control interfaces, visualization tools, and personalized settings can enhance usability and acceptance of CBIs in daily life.
  7. Ethical and Regulatory Frameworks: Establish robust ethical and regulatory frameworks to govern the development, deployment, and use of CBIs, addressing privacy, consent, data security, and potential risks associated with brain-computer communication and manipulation.
  8. Interdisciplinary Collaboration: Foster collaboration between neuroscientists, engineers, clinicians, ethicists, and end-users to address the multifaceted challenges of CBIs. Interdisciplinary research and innovation can drive breakthroughs in technology, neuroscience, and healthcare delivery, accelerating the translation of CBIs into clinical practice and everyday life.
By addressing these considerations, we can advance the development and adoption of CBIs for a wide range of applications, including medical diagnostics, therapeutic interventions, assistive technologies, and cognitive enhancement.
Please follow me if it's helpful. All the very best. Regards, Safiul
  • asked a question related to Medicine
Question
3 answers
Relevant answer
Answer
Am in support of your provided data Alexander Ohnemus
Imo, Jesse Daniel Brown has given a reasonable explanation of the university (financing) problem, in terms of economic organization of academia.
With respect to his prediction, formulated in the last sentence, I do also think that the information age will change education and research drastically, also in terms of accreditation standards, i.e. access to higher learning and earning pathways.
___________
The real University, he said, has no specific location. It owns no property, pays no salaries and receives no material dues. The real University is a state of mind. It is that great heritage of rational thought that has been brought down to us through the centuries and which does not exist at any specific location. It's a state of mind which is regenerated throughout the centuries by a body of people who traditionally carry the title of professor, but even that title is not part of the real University. The real University is nothing less than the continuing body of reason itself. In addition to this state of mind, 'reason,' there's a legal entity which is unfortunately called by the same name but which is quite another thing. This is a nonprofit corporation, a branch of the state with a specific address. It owns property, is capable of paying salaries, of receiving money and of responding to legislative pressures in the process. But this second university, the legal corporation, cannot teach, does not generate new knowledge or evaluate ideas. It is not the real University at all. It is just a church building, the setting, the location at which conditions have been made favorable for the real church to exist.
Robert Pirsig,
Zen and the Art of Motorcycle Maintainance
  • asked a question related to Medicine
Question
1 answer
Dear Master Degree, MPhil, and PhD Research Scholars,
We're excited to invite you to the CIMPA School 2024 on Mathematics for Medicine and Health Sciences at Silpakorn University in Thailand.
The CIMPA School will be held from May 20 to May 31 2024 at our esteemed university campus. This school aims to provide participants with in-depth knowledge and practical skills in the application of mathematics in the fields of medicine and health sciences. The program offers a diverse range of courses and training sessions led by renowned experts in their respective fields.
During the school, you will have the opportunity to attend introductory courses that cover various topics such as pharmacokinetics, disease modeling, big data analysis, and numerical implementation of blood flow. Additionally, advanced courses will delve into specialized areas like big data and machine learning for public health, modeling of waterborne diseases, and coagulation-fragmentation modeling.
The CIMPA School at Silpakorn University will serve as a platform for interdisciplinary exchange, fostering collaborations among participants from different countries and backgrounds. You will not only gain valuable knowledge but also have the chance to network with fellow researchers and professionals, opening doors to future collaborations and opportunities.
We are pleased to inform you that CIMPA is offering financial support for eligible participants. If you require financial assistance, we encourage you to apply for CIMPA financial support through their website: https://www.cimpa.info/en/node/40
To learn more about the CIMPA School at Silpakorn University, please visit our official website: https://sites.google.com/view/cimpa-silpakorn2024/. You will find detailed information regarding the registration procedure, program schedule, and other relevant details.
We believe that your expertise and contributions would greatly enrich the learning experience for all participants. Your presence at the CIMPA School would be highly valued, and we look forward to welcoming you to Silpakorn University.
If you have any questions or require further information, please do not hesitate to reach out to us ( pornsawad_p@su.ac.th or pornsawad_p@silpakorn.edu).
Thank you for your attention, and we hope to see you at the CIMPA School at Silpakorn University.
Best regards,
P. Pornsawad
Coordinators
Relevant answer
Answer
I,m interested. Sorry for being late.
  • asked a question related to Medicine
Question
3 answers
Recommended Topics
  • Assessing learning outcomes /assessment strategies in health professions education;
  • Bridging the gap between academia and professionals;
  • Case Based/Problem Based/Project Based Learning in health professions education;
  • Comparative analysis of teaching pedagogies;
  • Competency-based training for the modern health workforce;
  • Curricula design and accreditation;
  • E-learning innovations in health professions education;
  • Evolution of health professions roles in the changing healthcare landscape;
  • Future trends in health professions education;
  • Inclusion, diversity and accessibility in health professions graduate programs;
  • Integrating digital health technologies into curricula;
  • Integrating evidence-based practice education in health professions curricula;
  • International perspectives on health professions education;
  • Lifelong learning for health professionals;
  • Perspectives on learning and teaching in health professions education;
  • Simulation based learning;
  • The impact of undergraduate interventions on patient outcomes;
Relevant answer
Answer
I like your "Future trends in health professions education" chapter because the education of a healthcare professional is of foremost relevance in his or her functioning as that professional. And the future should rely on the past to mold the techniques in schooling. I wish you success in your chapter-writing as some of my published papers have been referenced in chapters in books. Good luck!
  • asked a question related to Medicine
Question
3 answers
S-Existence : There is Another Existence of Everything'
This theory could bring revolutionary changes in the field of medicine. Please read and give your feedback. thank you
Relevant answer
Answer
S-Existence denote the additional existence of everything, which is subtler and unperceived compared to the material existence.
S-Existence = f(M,E)
Where:
f represents the function that characterizes the S-Existence.
M represents the material existence, including fundamental particles, elements, matter, and energy.
E represents the S-Existence, which encompasses the formations, components, qualities, and energies present in a subtler, unperceived form.
Furthermore, when there is an interaction between material entities, there is a corresponding interaction and change between their S-Existences, indicating a parallel existence at a subtler level. This could be expressed as:
ΔS-Existence = g(ΔM)
Where:
ΔS-Existence represents the change in S-Existence.
g is a function describing how changes in material existence (ΔM) correspond to changes in S-Existence.
  • asked a question related to Medicine
Question
3 answers
📢 Call for Papers Announcement: New Asian Journal of Medicine (NAJM) - Volume 2, Issue 1, 2024 📚🔬
🌟 ISSN: 3005-8902
The New Asian Journal of Medicine (NAJM) is excited to invite researchers and clinicians to submit their groundbreaking work for our first issue of 2024. This marks our third serial issue since establishment, and we're proud to continue promoting impactful knowledge in medicine, medical science, and public health. 🌏💉
🎉 2024: A Year of Open Access and No Publication Charges! In our commitment to fostering global research collaborations and ensuring widespread accessibility of vital medical research, NAJM will operate as a fully open-access journal throughout 2024, without any publication charges. 🌐✨
🗓️ Submission Deadline: 15 Mars 2024
📩 For any queries or to submit your work, please reach out to our editorial office at editor@nasianjmed.com. We eagerly await your valuable contributions, which are instrumental in advancing medical knowledge and improving health outcomes worldwide. 💌👩‍🔬
👥 Tag a colleague or a researcher who might be interested! Let's collaborate to advance the frontiers of medical science.
Relevant answer
Answer
Great to see your post.
Thank You.